Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
CN Stock MarketDetailed Quotes
Cachet Pharmaceutical (002462)
- 13.50
- -0.36-2.60%
Market Closed May 15 15:00 CST
3.94BMarket Cap38.14P/E (TTM)
13.90High13.39Low61.56KlotVolume13.80Open13.86Prev Close83.81MTurnover2.11%Turnover Ratio35.34P/E (Static)291.71MShares19.6952wk High0.90P/B3.93BFloat Cap12.6052wk Low15.25Limit Up291.47MShs Float83.34Historical High12.47Limit Down3.68%Range %3.57Historical Low0.17Dividend TTM13.62Avg Price39.26KlotAsk1.26%Div Yield TTM100Lot Size21.02KlotBid
Cachet Pharmaceutical (002462) Cash Flow
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -14.76%4.42B | -17.91%22.69B | -20.85%16.68B | -25.11%10.95B | -38.17%5.18B | -16.92%27.65B | -18.20%21.08B | -14.66%14.62B | 8.89%8.38B | 18.03%33.28B |
| Refunds of taxes and levies | -72.03%192.5K | -38.79%3.65M | -55.67%1.93M | -86.83%732.34K | -82.92%688.33K | -51.61%5.97M | -46.25%4.35M | -20.06%5.56M | -36.02%4.03M | -30.95%12.33M |
| Cash received relating to other operating activities | -22.73%25.2M | -17.10%142.18M | -11.54%127.56M | 20.80%88.18M | -39.13%32.62M | -44.76%171.51M | -67.44%144.2M | -69.10%72.99M | -45.01%53.58M | -38.59%310.46M |
| Cash inflows from operating activities | -14.82%4.44B | -17.91%22.84B | -20.79%16.81B | -24.90%11.04B | -38.20%5.22B | -17.19%27.82B | -19.04%21.23B | -15.41%14.7B | 8.18%8.44B | 17.01%33.6B |
| Goods services cash paid | -13.03%4.36B | -21.60%20.47B | -24.17%15.17B | -28.54%10.11B | -35.95%5.01B | -13.94%26.11B | -15.94%20B | -9.26%14.14B | 16.71%7.83B | 13.23%30.34B |
| Staff behalf paid | -9.05%105.72M | -9.52%394.99M | -5.97%297.38M | -5.00%208.07M | -0.24%116.24M | -12.10%436.54M | -7.39%316.27M | 0.18%219.02M | 0.15%116.52M | -4.74%496.63M |
| All taxes paid | 66.34%138.07M | -39.18%365.14M | -36.43%276.82M | -39.77%183.75M | -27.08%83M | 37.71%600.33M | 5.15%435.45M | 6.84%305.11M | 10.73%113.83M | -13.05%435.95M |
| Cash paid relating to other operating activities | 0.11%47.89M | -55.91%219.91M | -53.13%139.19M | -64.40%86.76M | -55.55%47.83M | -32.15%498.82M | -63.58%296.97M | -43.93%243.7M | -38.54%107.62M | -30.98%735.17M |
| Cash outflows from operating activities | -11.57%4.65B | -22.41%21.45B | -24.56%15.88B | -29.01%10.59B | -35.58%5.26B | -13.63%27.64B | -17.02%21.05B | -9.77%14.91B | 14.99%8.16B | 10.82%32B |
| Net cash flows from operating activities | -376.16%-207.74M | 671.92%1.39B | 428.56%932.24M | 314.45%453.21M | -115.85%-43.63M | -88.70%180.36M | -79.28%176.37M | -124.83%-211.33M | -60.77%275.33M | 1,076.11%1.6B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | --300K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -67.68%3.52M |
| Cash received from returns on investments | ---- | --225.87K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --142.54K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -90.62%95.96K | -99.58%1.95M | -99.49%1.63M | -13.13%1.25M | 1.68%1.02M | 7,381.93%463.27M | 10,965.63%317.56M | -39.34%1.44M | -30.81%1.01M | 6.87%6.19M |
| Net cash received from disposal of subsidiaries and other business units | --10.04M | 84.46%19.58M | -93.12%791.6K | -99.83%19.12K | ---- | --10.62M | --11.5M | --11.5M | --11.5M | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --4.19M |
| Cash inflows from investing activities | 891.04%10.14M | -95.35%22.06M | -99.26%2.43M | -90.21%1.27M | -91.82%1.02M | 3,274.16%473.89M | 11,366.48%329.06M | 446.68%12.94M | 760.30%12.51M | -15.85%14.04M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -11.54%1.62M | 47.78%22.79M | 26.89%13.02M | 3.05%9.82M | -38.47%1.83M | -92.26%15.42M | -27.61%10.26M | -11.86%9.53M | -34.97%2.97M | 5.71%199.3M |
| Cash paid to acquire investments | ---- | ---- | ---- | ---- | ---- | --90.46M | 1,181.77%90.46M | 551.40%45.53M | -84.48%720.12K | ---- |
| Cash paid relating to other investing activities | ---- | --5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | -11.54%1.62M | -73.75%27.79M | -87.08%13.02M | -82.16%9.82M | -50.47%1.83M | -46.87%105.88M | 374.43%100.72M | 209.25%55.06M | -59.91%3.69M | 3.73%199.3M |
| Net cash flows from investing activities | 1,158.05%8.52M | -101.56%-5.74M | -104.64%-10.59M | 79.69%-8.56M | -109.13%-805.35K | 298.65%368M | 1,343.74%228.34M | -172.85%-42.12M | 213.72%8.82M | -5.59%-185.25M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | -53.63%7.35M | ---- | --0 | ---- | -74.23%15.85M | -77.15%12.93M | -77.77%11.93M | -67.59%9.45M | -9.58%61.5M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | -53.63%7.35M | ---- | --0 | ---- | -74.23%15.85M | -77.15%12.93M | -77.77%11.93M | -67.59%9.45M | -9.58%61.5M |
| Cash from borrowing | -28.84%515.94M | -30.63%2.19B | -36.17%1.56B | -11.52%1.27B | 23.29%725.06M | -37.10%3.16B | -35.80%2.44B | -48.28%1.43B | -65.60%588.11M | 2.22%5.03B |
| Cash received relating to other financing activities | -78.27%11.15M | -47.91%278.11M | -2.05%164.2M | 42.83%129.2M | 123.48%51.32M | 257.41%533.92M | -59.00%167.64M | -23.88%90.45M | 149.63%22.97M | 13.69%149.39M |
| Cash inflows from financing activities | -32.11%527.09M | -33.21%2.48B | -34.31%1.72B | -9.01%1.4B | 25.12%776.39M | -29.14%3.71B | -38.57%2.62B | -47.83%1.54B | -64.50%620.52M | 2.36%5.24B |
| Borrowing repayment | -20.02%557.25M | -20.44%3.04B | -22.19%2.26B | -14.87%1.57B | -8.47%696.75M | -27.39%3.82B | -36.03%2.91B | -40.59%1.84B | -57.81%761.2M | 13.81%5.26B |
| Dividend interest payment | -81.89%6.66M | -33.36%235.56M | -9.17%256.47M | -52.67%96.48M | -44.76%36.77M | -10.03%353.49M | -15.12%282.37M | 20.85%203.84M | 69.94%66.56M | -1.52%392.9M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | -31.86%126.69M | -9.02%88.93M | -93.96%4.46M | -92.15%2.69M | 4.12%185.92M | -24.88%97.74M | 227.06%73.9M | --34.3M | 53.05%178.56M |
| Cash payments relating to other financing activities | -65.62%23.26M | -41.71%260.89M | -25.37%195.72M | 8.63%125.06M | 249.37%67.66M | 101.76%447.55M | 73.52%262.27M | 38.04%115.12M | 99.94%19.37M | -16.06%221.83M |
| Cash outflows from financing activities | -26.71%587.17M | -23.49%3.53B | -21.36%2.72B | -17.18%1.79B | -5.42%801.17M | -21.35%4.62B | -31.36%3.45B | -35.54%2.16B | -54.29%847.12M | 11.15%5.87B |
| Net cash flows from financing activities | -142.42%-60.08M | -16.40%-1.05B | -19.53%-992.49M | 37.35%-390.34M | 89.06%-24.78M | -43.27%-904.71M | -9.08%-830.31M | -53.87%-623.01M | -115.98%-226.6M | -287.82%-631.49M |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | -274.62%-259.3M | 193.55%333.37M | 83.35%-70.84M | 106.20%54.31M | -220.27%-69.22M | -145.76%-356.35M | -694.14%-425.59M | -303.37%-876.47M | -90.23%57.55M | 255.21%778.7M |
| Add:Begin period cash and cash equivalents | 15.71%2.45B | -14.38%2.12B | -14.38%2.12B | -14.38%2.12B | -14.38%2.12B | 45.83%2.48B | 45.83%2.48B | 45.83%2.48B | 45.83%2.48B | -22.80%1.7B |
| End period cash equivalent | 6.98%2.2B | 15.71%2.45B | -0.08%2.05B | 35.87%2.18B | -19.05%2.05B | -14.38%2.12B | 15.89%2.05B | -24.82%1.6B | 10.80%2.54B | 45.83%2.48B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm